Si-pei Wu

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Genomic and immune characteristics of HER2-mutated non-small-cell lung cancer and response to immune checkpoint inhibitor-based therapy.

Genomic and immune characteristics of HER2-mutated non-small-cell lung cancer and response to immune checkpoint inhibitor-based therapy.

Journal: Molecular oncology

Published: December 14, 2022

Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients.

Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients.

Journal: Cancer medicine

Published: March 20, 2022

A novel miR-200c/c-myc negative regulatory feedback loop is essential to the EMT process, CSC biology and drug sensitivity in nasopharyngeal cancer.

A novel miR-200c/c-myc negative regulatory feedback loop is essential to the EMT process, CSC biology and drug sensitivity in nasopharyngeal cancer.

Journal: Experimental cell research

Published: August 21, 2019

Clinical relevance of PD-L1 expression and CD8+ T cells infiltration in patients with EGFR-mutated and ALK-rearranged lung cancer.

Clinical relevance of PD-L1 expression and CD8+ T cells infiltration in patients with EGFR-mutated and ALK-rearranged lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 22, 2018

A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer.

A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: September 07, 2017

Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.

Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: June 30, 2017

Epidermal growth factor receptor is associated with the onset of skeletal related events in non-small cell lung cancer.

Epidermal growth factor receptor is associated with the onset of skeletal related events in non-small cell lung cancer.

Journal: Oncotarget

Published: February 21, 2017

Acquired MET Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors in Non-Small Cell Lung Cancer.

Acquired MET Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors in Non-Small Cell Lung Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 20, 2016

Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma.

Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 11, 2016

Potential biomarker for checkpoint blockade immunotherapy and treatment strategy.

Potential biomarker for checkpoint blockade immunotherapy and treatment strategy.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: October 20, 2015

MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells.

MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells.

Journal: Cancer research

Published: December 28, 2012

Nuclear β-catenin accumulation is associated with increased expression of Nanog protein and predicts poor prognosis of non-small cell lung cancer.

Nuclear β-catenin accumulation is associated with increased expression of Nanog protein and predicts poor prognosis of non-small cell lung cancer.

Journal: Journal of translational medicine

Published: December 24, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026